PH Biorepository for Translational Research

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational effort creates a multi-center repository of biological samples and related clinical data from patients with pulmonary hypertension (PH) classified in groups 1-5. Researchers will collect blood at visits (about 3 tablespoons) and review medical records to link samples with clinical information. The study may include follow-up visits where additional blood is drawn and updated health data are gathered, with participation continuing while the project is active. Future protocols may use the stored samples to develop multimodal tests that help distinguish PH groups and predict outcomes. The aim is to enable discovery of non-invasive biomarkers and molecular phenotypes to improve PH diagnosis and management.

Why it matters

Who can join: the full rules

* INCLUSION CRITERIA:
* Provision of signed and dated informed consent form
* Males and females aged \>=18 years old
* Suspected of or diagnosed with PH
* Able to understand and willing to sign a written informed consent document

EXCLUSION CRITERIA:

Any individual who does not meet all inclusion criteria or is deemed by the local investigator not to be a blood draw candidate will be excluded from participating in this study.

Where it's running

• National Institutes of Health Clinical Center
  Bethesda, Maryland, United States Recruiting
• University of Maryland Medical Center at Baltimore (UMB)
  Baltimore, Maryland, United States Not yet recruiting
• INOVA Fairfax Hospital
  Falls Church, Virginia, United States Not yet recruiting

Study contacts

• Principal investigator: Michael A Solomon, M.D. — National Institutes of Health Clinical Center (CC)
• Study coordinator: Michael A Solomon, M.D.
• Email: msolomon@cc.nih.gov
• Phone: (301) 496-9320

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levosimendan to see if it helps the heart after PEA in CTEPH

  This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk · NCT07914933

• Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD

  This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.

  Recruiting at 2 sites Early Phase 1 Valley Health System · Paramus, New Jersey and 1 other locations · NCT07837830

• Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

  This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

  Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre · NCT07822997

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Pulmonary Artery Denervation for Pulmonary Hypertension After M-TEER

  This study tests whether PADN can help people with pulmonary hypertension after M-TEER compared with standard medical therapy.

  Recruiting Early Phase 1 Xiamen Cardiovascular Hospital, Xiamen University · Xiamen, Fujian · NCT07662655

• Risk Factor Assessment for Acute Pulmonary Hypertension Crisis

  This study tests how to identify people with pulmonary hypertension who are at risk of a sudden, life-threatening crisis.

  Recruiting at 4 sites Peking Union Medical College Hospital · Guangzhou, Guangdong and 3 other locations · NCT07653958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.